Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Myocardial Infarction in the Perioperative Setting (MIPS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03837535
Recruitment Status : Completed
First Posted : February 12, 2019
Last Update Posted : February 20, 2020
Sponsor:
Information provided by (Responsible Party):
Max Bell, Karolinska University Hospital

Brief Summary:
Acute myocardial infarction (AMI) is a significant complication following non-cardiac surgery. The investigators sought to evaluate incidence of perioperative AMI, its preoperative and intraoperative risk factors and the outcomes after this complication.

Condition or disease Intervention/treatment
Myocardial Infarction Postoperative Myocardial Injury Intraoperative Complications Intraoperative Hypotension Peroperative Complication Procedure: Surgery

Show Show detailed description

Layout table for study information
Study Type : Observational [Patient Registry]
Actual Enrollment : 400742 participants
Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration: 1 Year
Official Title: Myocardial Infarction in the Perioperative Setting, a Swedish Multi Center Cohort Study
Actual Study Start Date : January 1, 2019
Actual Primary Completion Date : December 31, 2019
Actual Study Completion Date : December 31, 2019

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Heart Attack

Group/Cohort Intervention/treatment
Patients undergoing surgery
Swedish patients, >18 years undergoing surgery 2007-2014
Procedure: Surgery
Neuro, Lung/thorax, GI, Gynecologic, Urologic, Orthopedic, Vascular surgery




Primary Outcome Measures :
  1. Acute Myocardial Infarction [ Time Frame: Within 30days of the index surgery ]
    AMI, as detected in the postoperative phase in the electronic medical records or in the Swedeheart registry


Secondary Outcome Measures :
  1. Mortality [ Time Frame: Within 30days of the index surgery and at later predefined time points: 60, 90, 180 and 365 days after the index surgery ]
    Death, as detected in the postoperative phase in the Swedish cause of death register


Other Outcome Measures:
  1. Length of stay (LOS) [ Time Frame: LOS within the year after the index surgery ]
    Time spent in the hospital (number of days)

  2. Days at home alive within 30 days (DAH30) [ Time Frame: DAH30 is counted within 30days of the index surgery ]
    Time spent in the home after the index surgery, takes into account readmissions

  3. Risk of AMI and Mortality by gender, type of surgery, extent- and recency of comorbidity [ Time Frame: Within one year of the index surgery ]
    How above mentioned patient characteristics affect risk of AMI and mortality

  4. Secondary complications [ Time Frame: Secondary complications within one year of the index surgery ]
    AMI vs non-AMI patients and their risk of AKI, pneumonia, stroke, infections, thromboembolic complications

  5. Outcomes (AMI+Mortality+Complications) by hospital, region and year [ Time Frame: All outcomes within one year of the index surgery ]
    All outcomes as affected by hospital type, region and by year



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Adult patients undergoing non-cardiac surgery between 2007 and 2014 in Swedish Hospitals using the Orbit software surgical planning tool. This software system is used in all parts of Sweden and in all types of hospitals (University, County and District hospitals)

  • University hospitals: Huddinge, KS, Norrlands universitetssjukhus, MAS, USIL, ** County hospitals: NU-sjukvården, Sundsvalls, Södra Älvsborgs, Örnsköldsviks *** District hospitals: Helsingborgs lasarett, Hässleholms, Kristanstads, Kullbergska, Landskrona, Lycksele, Mälarsjukhuset, Nyköping, Sollefteå, Skellefteå Södertälje, Trelleborg, Ystad, Ängelholm, Privat Ortopedisk klinik
Criteria

Inclusion Criteria:

  • Adults (≥18 years), male and female
  • Undergoing elective or non-elective inpatient noncardiac surgery

Exclusion Criteria:

  • Cardiac surgery

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03837535


Locations
Layout table for location information
Sweden
Karolinska University Hospital
Stockholm, Sweden, 17176
Sponsors and Collaborators
Karolinska University Hospital
Investigators
Layout table for investigator information
Principal Investigator: Max Bell, MD, PhD Karolinska University Hospital, Karolinska Institutet
Additional Information:

Layout table for additonal information
Responsible Party: Max Bell, MD, PhD, Associate Professor, Senior Lecturer, Karolinska University Hospital
ClinicalTrials.gov Identifier: NCT03837535    
Other Study ID Numbers: Karolinska UH_PR
First Posted: February 12, 2019    Key Record Dates
Last Update Posted: February 20, 2020
Last Verified: February 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Yes
Plan Description: De-identified cohort data for primary and secondary endpoints will be shared.
Supporting Materials: Study Protocol
Statistical Analysis Plan (SAP)
Analytic Code
Time Frame: Data will be available within a year of study completion
Access Criteria: Data access will be reviewed by an external research committee at the department of perioperative medicine and intensive care at the Karolinska University Hospital

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Myocardial Infarction
Hypotension
Infarction
Intraoperative Complications
Ischemia
Pathologic Processes
Necrosis
Myocardial Ischemia
Heart Diseases
Cardiovascular Diseases
Vascular Diseases